Status:
COMPLETED
RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing
Lead Sponsor:
University of Cincinnati
Conditions:
Opioid-Related Disorders
Opioid-use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to: 1. assess how well individuals entering medication assisted treatment like the RETAIN e-health application as measured by their feedback on the intervention....
Detailed Description
The pre-post study of RETAIN will: 1) assess the acceptability of RETAIN as measured by participant feedback about the intervention; 2) test the impact of RETAIN on knowledge about MAT, as measured by...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Starting MAT with methadone or suboxone or in MAT for less than 2 weeks;
Exclusion
- Does not sign the "short form" consent form
Key Trial Info
Start Date :
November 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 6 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03411265
Start Date
November 8 2017
End Date
September 6 2018
Last Update
April 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cincinnati Addiction Sciences Division
Cincinnati, Ohio, United States, 45229